VIR
Vir Biotechnology Inc
NASDAQ: VIR · HEALTHCARE · BIOTECHNOLOGY
$10.22
+1.34% today
Updated 2026-04-30
Market cap
$1.72B
P/E ratio
—
P/S ratio
25.02x
EPS (TTM)
$-3.16
Dividend yield
—
52W range
$4 – $12
Volume
4.0M
Vir Biotechnology Inc (VIR) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $149000.00 | $868000.00 | $711000.00 | $76.37M | $1.10B | $1.62B | $86.18M | $74.20M | $68.56M |
| Revenue growth (YoY) | — | +482.6% | -18.1% | +10640.9% | +1334.4% | +47.5% | -94.7% | -13.9% | -7.6% |
| Cost of revenue | $62.51M | $100.23M | $143.07M | $301.58M | $513.87M | $620.97M | $572.83M | $478.64M | $11.71M |
| Gross profit | $-62.36M | $-99.36M | $711000.00 | $76.37M | $581.54M | $994.83M | $-486.65M | $-404.44M | $56.85M |
| Gross margin | -41854.4% | -11447.1% | 100.0% | 100.0% | 53.1% | 61.6% | -564.7% | -545.0% | 82.9% |
| R&D | $62.51M | $100.23M | $148.47M | $302.41M | $448.01M | $474.65M | $579.72M | $506.50M | $432.80M |
| SG&A | $21.69M | $29.13M | $37.60M | $70.94M | $160.79M | $161.76M | $173.70M | $119.03M | $92.07M |
| Operating income | $-81.50M | $-118.69M | $-177.98M | $-296.98M | $420.75M | $833.07M | $-684.30M | $-587.16M | $-468.02M |
| Operating margin | -54696.0% | -13674.2% | -25032.2% | -388.9% | 38.4% | 51.6% | -794.0% | -791.3% | -682.7% |
| EBITDA | $-81.06M | $-115.94M | $-173.46M | $514.33M | $426.56M | $839.85M | $-641.64M | $-508.91M | $-426.09M |
| EBITDA margin | -54406.0% | -13356.7% | -24396.9% | 673.5% | 38.9% | 52.0% | -744.5% | -685.8% | -621.5% |
| EBIT | $-81.50M | $-118.69M | $-177.98M | $-298.72M | $420.75M | $833.07M | $-661.09M | $-523.47M | $-437.77M |
| Interest expense | $0.00 | $0.00 | $7.97M | $3.81M | $272.91M | $183.15M | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-69.85M | $-115.88M | $-174.68M | $-298.67M | $528.58M | $515.84M | $-615.06M | $-521.96M | $-437.99M |
| Net income growth (YoY) | — | -65.9% | -50.7% | -71.0% | +277.0% | -2.4% | -219.2% | +15.1% | +16.1% |
| Profit margin | -46880.5% | -13350.7% | -24568.6% | -391.1% | 48.3% | 31.9% | -713.7% | -703.4% | -638.9% |